Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05559372 · ClinicalTrials.gov registry record · NA
Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes
A NA study, sponsored by Nathaniel Jenkins.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT05559372: Completed NA study, sponsored by Nathaniel Jenkins.
NCT05559372 is a NA study that has completed, run by Nathaniel Jenkins. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05559372, a NA study, has completed, sponsored by Nathaniel Jenkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
Energy drinks are widely promoted to increase energy, enhance mental alertness, and improve physical performance. ccording to the National Center for Complementary and Integrative Health (NCCIH) at NIH \[1\], next to multivitamins, energy drinks are the most popular dietary supplement consumed by American teens and young adults. No two energy drinks are the same, with each using different ingredients. Traditionally, energy drinks contained caffeine, sugar, ginseng and B-vitamins, but newer competitors are bringing different formulations to the market that are also low-calorie/low-sugar and that contain other performance enhancing ingredients, such as beta-alanine and l-citrulline. There are also significant concerns regarding the safety of energy drink consumption. Unfortunately, there are few studies that have (1) examined the effects of energy drink consumption on performance and cardiovascular safety, nor (2) compared these effects among brands with different formulations to examine their safety and efficacy relative to each other and such studies are desperately needed, especially with the growing popularity of energy drinks \[3,4\].
Primary Outcome
Maximal oxygen consumption during ramp cycle test
Interventions
- DIETARY_SUPPLEMENT Acute energy drink or placebo consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-03-04 |
| Phase | NA |
What the finished NCT05559372 record still lists
NCT05559372 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Acute energy drink or placebo consumption is the first listed.
NCT05559372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05559372 about?
NCT05559372 is a clinical study titled "Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes". Energy drinks are widely promoted to increase energy, enhance mental alertness, and improve physical performance. ccording to the National Center for Complementary and Integrative Health (NCCIH) at NIH \[1\], next to multivitamins, energy drinks are the most popular dietary supplement consumed by Am...
What is the current status of trial NCT05559372?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2021-10-25. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT05559372?
The interventions under investigation include: Acute energy drink or placebo consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05559372?
This trial is sponsored by Nathaniel Jenkins, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05559372's enrollment target sits among peer trials
109 825th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI